Market

Mizuho initiates coverage on Kymera Therapeutics stock with Outperform rating

Mizuho initiates coverage on Kymera Therapeutics stock with Outperform rating
Read More

Related Posts

New York Times sues Perplexity AI for ’illegal’ copying of content

New York Times sues Perplexity AI for ’illegal’ copying...

‘I am increasingly resentful’: My husband of 10 years has $1 million and cars worth $200K. Why won’t he give me money?

‘I am increasingly resentful’: My husband of 10 years h...

Our Roth conversion triggered extra fees for Medicare premiums. Can I appeal?

Our Roth conversion triggered extra fees for Medicare p...

Mendonca, Wabtec president, sells $433k in WAB stock

Mendonca, Wabtec president, sells $433k in WAB stock

This Tesla move could help the EV maker shake a sales slump

This Tesla move could help the EV maker shake a sales s...

Two of Brazil’s nine central bank seats likely to be unfilled at January meeting, sources say

Two of Brazil’s nine central bank seats likely to be un...